These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 29390403)

  • 1. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery.
    Ma H; Wang Z; Xu K; Shao Z; Yang C; Xu P; Liu X; Hu C; Lu X; Rong Y
    Exp Ther Med; 2017 Jun; 13(6):2691-2698. PubMed ID: 28587332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas.
    Rau MK; Braun C; Skardelly M; Schittenhelm J; Paulsen F; Bender B; Ernemann U; Bisdas S
    J Neurooncol; 2014 Dec; 120(3):557-66. PubMed ID: 25154323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
    Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
    BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
    Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
    Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
    Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
    Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma.
    Roy B; Awasthi R; Bindal A; Sahoo P; Kumar R; Behari S; Ojha BK; Husain N; Pandey CM; Rathore RK; Gupta RK
    J Comput Assist Tomogr; 2013; 37(3):321-6. PubMed ID: 23673999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossed cerebellar diaschisis in post-treatment glioma patients: A comparative study of arterial spin labelling and dynamic susceptibility contrast.
    Lin T; Lyu Y; Qu J; Cheng X; Fan X; Zhang Y; Hou B; You H; Ma W; Feng F
    Eur J Radiol; 2018 Oct; 107():70-75. PubMed ID: 30292276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
    Wong AM; Yan FX; Liu HL
    J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of 3D Arterial Spin Labeling and Multi-Parametric Dynamic Susceptibility Contrast Perfusion MRI in Brain Tumors.
    Khashbat Md D; Abe Md T; Ganbold Md M; Iwamoto Md S; Uyama Md N; Irahara Md S; Otomi Md PhD Y; Harada Md PhD M; Kageji Md PhD T; Nagahiro Md PhD S
    J Med Invest; 2016; 63(3-4):175-81. PubMed ID: 27644554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
    Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
    Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of Arterial Spin-Labeling, Dynamic Contrast-Enhanced, and DSC Perfusion Imaging in the Diagnosis of Recurrent High-Grade Gliomas: A Prospective Study.
    Nguyen TB; Zakhari N; Velasco Sandoval S; Guarnizo-Capera A; Alexios Gulak M; Woulfe J; Jansen G; Thornhill R; Majtenyi N; Cron GO
    AJNR Am J Neuroradiol; 2023 Feb; 44(2):134-142. PubMed ID: 36702501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma.
    Manning P; Daghighi S; Rajaratnam MK; Parthiban S; Bahrami N; Dale AM; Bolar D; Piccioni DE; McDonald CR; Farid N
    J Neurooncol; 2020 May; 147(3):681-690. PubMed ID: 32239431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging.
    Wang YL; Chen S; Xiao HF; Li Y; Wang Y; Liu G; Lou X; Ma L
    Radiother Oncol; 2018 Oct; 129(1):68-74. PubMed ID: 29398151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radiomics-based comparative study on arterial spin labeling and dynamic susceptibility contrast perfusion-weighted imaging in gliomas.
    Hashido T; Saito S; Ishida T
    Sci Rep; 2020 Apr; 10(1):6121. PubMed ID: 32273523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Consistency analysis between 3D arterial spin labeling and dynamic susceptibility contrast perfusion magnetic resonance imaging in perfusion imaging of brain tumor].
    Chen S; Wang L; Wang L; Zheng C; Yang K
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1283-1286. PubMed ID: 34549723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Accuracy of Arterial Spin Labeling in Comparison With Dynamic Susceptibility Contrast-Enhanced Perfusion for Brain Tumor Surveillance at 3T MRI.
    Lavrova A; Teunissen WHT; Warnert EAH; van den Bent M; Smits M
    Front Oncol; 2022; 12():849657. PubMed ID: 35669426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
    Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
    Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.